Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment

S Novo1, M G Abrignani, M Corda

  • 1University of Catania, Italy.

European Heart Journal
|December 1, 1991
PubMed

Insights

Antihypertensive drugs like ACE inhibitors and beta-blockers can reduce blood pressure and reverse left ventricular hypertrophy (LVH). However, only ACE inhibitors partially improve vascular changes, while diuretics show no such benefits.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Research

Background:

  • Arterial hypertension frequently leads to left ventricular hypertrophy (LVH) and vascular structural changes, impacting compliance and organ damage.
  • LVH is a significant adverse prognostic factor, increasing risks of sudden death and ischemic heart disease events.
  • Vascular alterations contribute to maintaining high blood pressure and target organ damage.

Purpose of the Study:

  • To evaluate the effects of long-term antihypertensive drug use on blood pressure, left ventricular hypertrophy (LVH), ventricular arrhythmias, and vascular structural changes.
  • To compare the efficacy of different antihypertensive drug classes (calcium antagonists, ACE inhibitors, beta-blockers, diuretics) in reversing cardiovascular structural alterations.

Main Methods:

  • Literature review on long-term effects of antihypertensive medications.
  • Analysis of drug effects on blood pressure, LVH, ventricular arrhythmias, and vascular compliance.
  • Comparison of outcomes between ACE inhibitors, beta-blockers, calcium antagonists, and diuretics.

Main Results:

  • Long-term use of ACE inhibitors, beta-blockers, and calcium antagonists may revert LVH.
  • These drug classes also reduce blood pressure and associated ventricular arrhythmias.
  • ACE inhibitors partially reverse vascular structural changes, whereas beta-blockers do not; diuretics lack these beneficial effects.

Conclusions:

  • Long-term antihypertensive therapy with ACE inhibitors, beta-blockers, and calcium antagonists can beneficially impact cardiac structure and function beyond blood pressure reduction.
  • ACE inhibitors show a partial benefit in vascular remodeling, suggesting a role in mitigating hypertension-induced vascular damage.
  • Further research is needed to explore regional differences in cardiovascular regression and the specific effects of various antihypertensive agents.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.